| Net Cash Provided by (Used in) Operating Activities |
-828K |
USD |
-156% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
5.48M |
USD |
|
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
-1.33M |
USD |
+33.4% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
200M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
93.5M |
shares |
|
Q3 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
3.26M |
USD |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
56.5M |
USD |
+72.2% |
Q4 2024 |
FY 2024 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Gross |
62.7M |
USD |
+23.3% |
Q4 2024 |
FY 2024 |
| Payments to Acquire Property, Plant, and Equipment |
2.18M |
USD |
+9.43% |
Q1 2025 |
Q1 2025 |
| Property, Plant and Equipment, Gross |
317M |
USD |
+4.66% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
138M |
USD |
+20.5% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
2.92M |
USD |
-36.3% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
6.23M |
USD |
-65.5% |
Q4 2024 |
FY 2024 |
| Share-based Payment Arrangement, Expense |
1.23M |
USD |
+48.7% |
Q3 2025 |
Q3 2025 |